Patents by Inventor Micheline Lagranderie

Micheline Lagranderie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis
    Patent number: 8414865
    Abstract: Use of Mycobacterium bovis BCG killed by Extended Freeze Drying (EFD) for preventing or treating atherosclerosis.
    Type: Grant
    Filed: August 12, 2010
    Date of Patent: April 9, 2013
    Assignees: Institut Pasteur, Institut National de la Recherche Agronomique
    Inventors: Gilles Marchal, Micheline Lagranderie, Isabelle Schwartz-Cornil
  • Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
    Patent number: 8404250
    Abstract: This application relates to compositions comprising components prepared from Gram positive bacteria such as Gram positive facultative intracellular bacteria for treatment of disorders comprising an immune dysregulation in humans and animals.
    Type: Grant
    Filed: October 21, 2009
    Date of Patent: March 26, 2013
    Assignees: Institut Pasteur, Institut National de la Sante et de la Recherche Medicale
    Inventors: Marie-Anne Nahori, Micheline Lagranderie, Gilles Marchal, Bernardo Boris Vargaftig, Jean Lefort, Felix Romain, Georges Hekimian, Philippe Peltre
  • Use of Mycobacterium Bovis BCG killed by Extended Freeze Drying (EFD) For Preventing or Treating Atherosclerosis
    Publication number: 20120201856
    Abstract: Use of Mycobacterium bovis BCG killed by Extended Freeze Drying (EFD) for preventing or treating atherosclerosis.
    Type: Application
    Filed: August 12, 2010
    Publication date: August 9, 2012
    Applicant: BIOMET MANUFACTURING CORP.
    Inventors: Gilles Marchal, Micheline Lagranderie, Isabelle Schwartz-Cornil
  • Preparation Comprising Mycobacterium Bovis BCG Killed by Extended Freeze Drying (EFD) for Preventing or Treating Rheumatoid Arthritis
    Publication number: 20110033567
    Abstract: Preparation comprising Mycobacterium bovis BCG killed by Extended Freeze Drying (EFD) for preventing and/or treating rheumatoid arthritis.
    Type: Application
    Filed: February 6, 2009
    Publication date: February 10, 2011
    Inventors: Gilles Marchal, Micheline Lagranderie, Marie-Christophe Boissier, Natacha Bessis
  • Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation
    Patent number: 7871627
    Abstract: Compositions comprising components prepared from Gram positive bacteria such as Gram positive facultative intra-cellular bacteria, for example mycobacteria, including extended freeze-dried killed Gram positive bacteria, their method of preparation and their use in humans and animals, for the prevention and/or the treatment of disorders comprising an immune dysregulation such as cancer, autoimmune diseases, allergy and tuberculosis.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: January 18, 2011
    Assignees: Institut Pasteur, Institut National de la Sante Et de la Recherche Medicale (INSERM)
    Inventors: Marie-Anne Nahori, Micheline Lagranderie, Gilles Marchal, Bernardo Boris Vargaftig, Jean Lefort, Felix Romain, Georges Hekimian, Philippe Peltre
  • GRAM POSITIVE BACTERIA PREPARATIONS FOR THE TREATMENT OF DISEASES COMPRISING AN IMMUNE DYSREGULATION
    Publication number: 20100272756
    Abstract: This application relates to compositions comprising components prepared from Gram positive bacteria such as Gram positive facultative intracellular bacteria for treatment of disorders comprising an immune dysregulation in humans and animals.
    Type: Application
    Filed: October 21, 2009
    Publication date: October 28, 2010
    Applicants: INSTITUT PASTEUR, INSTITUT NAT DE LA SANTE ET DE LA RECHERCHE MED
    Inventors: Marie-Anne NAHORI, Micheline Lagranderie, Gilles Marchal, Bernardo Boris Vargaftig, Jean Lefort, Félix Romain, Georges Hekimian, Philippe Peltre
  • CONTROL OF INTESTINAL INFLAMMATORY SYNDROMES WITH A PREPARATION OF KILLED OR NON INFECTIOUS BACTERIA
    Publication number: 20090280146
    Abstract: This invention relates to the use of a preparation of killed or non infectious Gram positive bacteria such as Gram positive facultative intracellular bacteria, for example mycobacteria, for the treatment of intestinal inflammatory syndromes such as Crohn's disease or ulcerative colitis.
    Type: Application
    Filed: December 21, 2006
    Publication date: November 12, 2009
    Applicants: INSTITUT PASTEUR, YISSUM RESEARCH DEVELOPMENT COMPANY
    Inventors: Gilles Marchal, Micheline Lagranderie, Mohammad Abolhassani, Herve Bercovier
  • Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation
    Publication number: 20070190076
    Abstract: Compositions comprising components prepared from Gram positive bacteria such as Gram positive facultative intra-cellular bacteria, for example mycobacteria, including extended freeze-dried killed Gram positive bacteria, their method of preparation and their use in humans and animals, for the prevention and/or the treatment of disorders comprising an immune dysregulation such as cancer, autoimmune diseases, allergy and tuberculosis.
    Type: Application
    Filed: November 17, 2006
    Publication date: August 16, 2007
    Inventors: Marie-Anne Nahori, Micheline Lagranderie, Gilles Marchal, Bernado Vargaftig, Jean Lefort, Felix Romain, Georges Hekimian, Philippe Peltre
  • Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
    Publication number: 20060062807
    Abstract: Compositions comprising components prepared from Gram positive bacteria such as Gram positive facultative intra-cellular bacteria, for example mycobacteria, including extended freeze-dried killed Gram positive bacteria, their method of preparation and their use in humans and animals, for the prevention and/or the treatment of disorders comprising an immune dysregulation such as cancer, autoimmune diseases, allergy and tuberculosis.
    Type: Application
    Filed: December 11, 2002
    Publication date: March 23, 2006
    Inventors: Marie-Anne Nahori, Micheline Lagranderie, Gilles Marchal, Bernado Vargaftig, Jean Lefort, Felix Romain, Georges Hekimian, Philippe Peltre